A similar ‘late tau’ subtype was found by another study that applied SuStaIn to CSF and PET.23 Several other works have previously studied the differences between subjects presenting a typical Alzheimer’s disease progression with high or low levels of Tau. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.